FINWIRES · TerminalLIVE
FINWIRES

Amneal Pharmaceuticals Insider Sold Shares Worth $3,771,050, According to a Recent SEC Filing

By

Jason B. Daly, Executive Vice President, Chief Legal Officer, on August 11, 2026, sold 216,613 shares in Amneal Pharmaceuticals (AMRX) for $3,771,050. Following the Form 4 filing with the SEC, Daly has control over a total of 35,171 Class A common shares of the company, with 35,171 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1723128/000162828026056754/xslF345X05/wk-form4_1786652494.xml

Related Articles